Grufity logoGrufity logo

Teladoc Inc Stock Research

TDOC

25.22USD+0.22(+0.88%)Market Closed

Market Summary

USD25.22+0.22
Market Closed
0.88%

TDOC Alerts

TDOC Stock Price

TDOC RSI Chart

TDOC Valuation

Market Cap

4.1B

Price/Earnings (Trailing)

-0.3

Price/Sales (Trailing)

1.71

EV/EBITDA

-0.24

Price/Free Cashflow

23.76

TDOC Price/Sales (Trailing)

TDOC Profitability

EBT Margin

-567.69%

Return on Equity

-591.9%

Return on Assets

-314.35%

Free Cashflow Yield

4.21%

TDOC Fundamentals

TDOC Revenue

Revenue (TTM)

2.4B

Revenue Y/Y

15.06%

Revenue Q/Q

4.3%

TDOC Earnings

Earnings (TTM)

-13.7B

Earnings Y/Y

-34.6K%

Earnings Q/Q

-5.1K%

Price Action

52 Week Range

21.6077.50
(Low)(High)

Last 7 days

-1.4%

Last 30 days

-16.9%

Last 90 days

-7.3%

Trailing 12 Months

-54.1%

TDOC Financial Health

Current Ratio

3.29

TDOC Investor Care

Shares Dilution (1Y)

1.48%

Diluted EPS (TTM)

-84.6

Peers (Alternatives to Teladoc)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
70.6B
60.2B
-4.86% -6.89%
12.5
1.17
2.52% -18.88%
27.9B
-
0.98% 20.75%
47.36
4.81
- -
27.3B
2.1B
-0.47% -1.83%
68.93
13.15
17.88% -8.53%
19.6B
14.9B
-11.65% -18.57%
15.35
1.32
-7.72% -46.20%
MID-CAP
9.0B
3.5B
11.88% 31.28%
-116.8
2.57
7.15% -34.72%
4.1B
2.4B
-16.92% -54.15%
-0.3
1.71
18.41% -3085.58%
2.5B
1.3B
1.97% -58.05%
451.35
1.97
14.48% -92.74%
SMALL-CAP
1.8B
262.3M
-10.85% 40.30%
-9.92
6.98
33.16% -131.28%
1.5B
837.2M
-24.90% -38.38%
24.16
1.75
3.88% -92.18%
1.1B
625.9M
-11.35% -14.10%
49.5
1.81
6.21% 3223.77%
864.4M
53.5M
4.26% 2.91%
80.77
16.17
10.94% 3.61%
657.1M
276.2M
-14.12% -43.94%
-4.78
2.38
14.18% 10.32%
234.3M
63.1M
-26.73% -64.73%
-22.34
3.71
9.93% -1043.45%
155.2M
357.1M
-7.94% 20.85%
-1.11
0.43
33.22% -57.66%
4.6M
4.3M
-19.40% -50.10%
-1.89
1.09
-12.25% 9.68%

Financials for Teladoc

Income Statement (Last 12 Months)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue3.6%2,406,840,0002,323,366,0002,233,622,0002,144,382,0002,032,707,000
  S&GA Expenses-1.3%227,172,000230,223,000238,191,000244,117,000250,581,000
  R&D Expenses1.4%333,629,000328,920,000321,355,000321,288,000311,884,000
EBITDA-38.4%-13,437,351,000-9,709,548,000-9,743,248,000-6,795,388,000-
EBITDA Margin-33.6%-5.58-4.18-4.36-3.17-
Earnings Before Taxes-37.8%-13,663,343,000-9,912,157,000-9,918,207,000-6,946,181,000-384,656,000
EBT Margin-33.1%-5.68-4.27-4.44-3.24-
Interest Expenses36.9%-30,035,000-47,584,000-63,720,000-80,365,000-
Net Income-38.5%-13,659,531,000-9,860,445,000-9,871,309,000-6,903,667,000-428,793,000
Net Income Margin-33.7%-5.68-4.24-4.42-3.22-
Free Cahsflow-10.8%172,812,000193,743,000209,937,000169,937,000-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-46.4%4,3458,1048,10311,09217,735
  Current Assets2.2%1,3151,2881,2571,2081,225
    Cash Equivalents2.1%918900881836893
  Inventory-5.1%56.0059.0060.0071.0073.00
  Net PPE8.7%30.0027.0027.0028.0027.00
  Goodwill-77.9%1,0734,8464,8587,90014,504
  Current Liabilities-2.8%400411371307331
    LT Debt, Current------
Shareholder's Equity-61.9%2,3086,0536,0859,14316,046
  Retained Earnings-34.0%-15,008-11,198-11,124-8,023-1,421
  Additional Paid-In Capital0.3%17,35917,30017,23917,17717,473
Shares Outstanding0.4%163162162161160
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-8.5%189207221180194
  Share Based Compensation-4.7%218229245277303
Cashflow From Investing-25.2%-167-133-127-84.52-72.98
Cashflow From Financing-25.7%6.009.009.0022.0041.00

Risks for TDOC

What is the probability of a big loss on TDOC?

96.2%


Probability that Teladoc stock will be more than 20% underwater in next one year

60.4%


Probability that Teladoc stock will be more than 30% underwater in next one year.

54.2%


Probability that Teladoc stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does TDOC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Teladoc was unfortunately bought at previous high price.

Drawdowns

Returns for TDOC

Cumulative Returns on TDOC

11.6%


7-Year Cumulative Returns

-9.5%


5-Year Cumulative Returns

-42.0%


3-Year Cumulative Returns

What are the long-term rolling returns for TDOC?

FIve years rolling returns for Teladoc.

Annualized Returns

Which funds bought or sold TDOC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
BAILLIE GIFFORD & CO
reduced
-9.49
-20,689,500
112,272,000
0.12%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-0.05
-30,453
416,547
-%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-20.85
-52,000
144,000
-%
2023-03-02
OLIVER LAGORE VANVALIN INVESTMENT GROUP
unchanged
-
-1,640
24,360
0.01%
2023-02-28
Voya Investment Management LLC
reduced
-0.66
-47,439
594,561
-%
2023-02-24
BBJS FINANCIAL ADVISORS, LLC
new
-
591
591
-%
2023-02-24
SRS Capital Advisors, Inc.
reduced
-0.36
-1,040
12,960
-%
2023-02-24
National Pension Service
unchanged
-
-57.00
520
-%
2023-02-24
NATIXIS
reduced
-95.59
-15,871,700
680,316
-%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
sold off
-100
-756,000
-
-%

1–10 of 43

Latest Funds Activity

Are funds buying TDOC calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own TDOC
No. of Funds

Teladoc News

MZP News

There is no shortage of investors who are bullish on Teladoc Health ....

MZP News,
9 hours ago

InvestorPlace

InvestorsObserver

The Motley Fool

The News Heater

The Motley Fool

Zacks Investment Research

The Motley Fool

The Motley Fool

The Motley Fool

The Motley Fool

The Motley Fool

Schedule 13G FIlings of Teladoc

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
8.94%
14,476,155
SC 13G/A
Feb 07, 2023
blackrock inc.
6.2%
9,961,219
SC 13G/A
Feb 03, 2023
sumitomo mitsui trust holdings, inc.
5.01%
8,125,231
SC 13G/A
Jul 05, 2022
baillie gifford & co
4.80%
7,739,623
SC 13G/A
Mar 11, 2022
blackrock inc.
5.9%
9,485,340
SC 13G/A
Feb 14, 2022
nikko asset management americas, inc.
5.47%
8,755,058
SC 13G
Feb 09, 2022
ark investment management llc
11.82%
18,922,198
SC 13G/A
Feb 08, 2022
blackrock inc.
5.9%
9,485,340
SC 13G
Feb 04, 2022
sumitomo mitsui trust holdings, inc.
5.70%
9,140,808
SC 13G
Jan 26, 2022
baillie gifford & co
6.79%
10,877,063
SC 13G/A

TDOC Fair Value

Teladoc fair value in different scenarios

The table shows the Fair Value estimates for Teladoc for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

2.78

-88.98%

6.06

-75.97%

16.14

-36.00%

34.85

38.18%

72.42

187.15%
Current Inflation

2.54

-89.93%

5.45

-78.39%

14.21

-43.66%

30.24

19.90%

62.23

146.75%
Very High Inflation

2.24

-91.12%

4.72

-81.28%

11.93

-52.70%

24.86

-1.43%

50.47

100.12%

Historical Teladoc Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Teladoc

View All Filings
Date Filed Form Type Document
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading

Latest Insider Trading transactions for TDOC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-03
Vandervoort Adam C
sold
-132,042
25.911
-5,096
chief legal officer, secretary
2023-03-03
GOREVIC JASON N
sold
-571,078
25.911
-22,040
chief executive officer
2023-03-03
Verstraete Stephany
sold
-74,442
25.911
-2,873
chief marketing officer
2023-03-03
Murthy Mala
sold
-192,726
25.911
-7,438
chief financial officer
2023-03-03
Turitz Andrew
sold
-46,510
25.911
-1,795
svp - corporate development
2023-03-03
Trencher Daniel
sold
-47,624
25.911
-1,838
svp corporate strategy
2023-03-02
Murthy Mala
sold
-192,878
25.362
-7,605
chief financial officer
2023-03-02
Jensen Claus Torp
sold
-85,926
25.362
-3,388
chief innovation officer
2023-03-02
GOREVIC JASON N
acquired
-
-
44,814
chief executive officer
2023-03-02
Verstraete Stephany
acquired
-
-
8,102
chief marketing officer

1–10 of 50

Jason N. Gorevic
5100
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

TDOC Income Statement

2022-12-31
Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Consolidated Statements of Operations and Other Comprehensive Loss   
Revenue$ 2,406,840$ 2,032,707$ 1,093,962
Expenses:   
Cost of revenue (exclusive of depreciation and amortization, which is shown separately below)743,987650,258390,829
Operating expenses:   
Advertising and marketing623,536416,726226,146
Sales227,172250,581154,052
Technology and development333,629311,884164,941
General and administrative449,855438,007506,684
Acquisition, integration, and transformation costs15,62026,64388,236
Restructuring costs7,41600
Depreciation and amortization256,027204,23969,495
Goodwill impairment13,402,81200
Total expenses16,060,0542,298,3381,600,383
Loss from operations(13,653,214)(265,631)(506,421)
Loss on extinguishment of debt043,7489,077
Other expense (income), net859(5,088)545
Interest expense, net9,27080,36559,950
Loss before provision for income taxes(13,663,343)(384,656)(575,993)
Provision for income taxes(3,812)44,137(90,857)
Net loss(13,659,531)(428,793)(485,136)
Other comprehensive income (loss), net of tax:   
Currency translation adjustment and other(36,491)(24,803)35,757
Comprehensive loss$ (13,696,022)$ (453,596)$ (449,379)
Net loss per share, basic (in dollars per share)$ (84.60)$ (2.73)$ (5.36)
Net loss per share, diluted (in dollars per share)$ (84.60)$ (2.73)$ (5.36)
Weighted-average shares used to compute basic net loss per share161,457,123156,939,34990,509,229
Weighted-average shares used to compute diluted net loss per share161,457,123156,939,34990,509,229

TDOC Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 918,182$ 893,480
Short-term investments02,537
Accounts receivable, net of allowance of $14,800 and $12,384, respectively210,554168,956
Inventories56,34273,079
Prepaid expenses and other current assets130,31087,387
Total current assets1,315,3881,225,439
Property and equipment, net29,64127,234
Goodwill1,073,19014,504,174
Intangible assets, net1,836,7651,910,278
Operating lease - right-of-use assets41,83146,780
Other assets48,54020,703
Total assets4,345,35517,734,608
Current liabilities:  
Accounts payable47,69047,257
Accrued expenses and other current liabilities168,693102,933
Accrued compensation81,55491,941
Deferred revenue-current90,45775,569
Advances from financing companies11,37513,313
Total current liabilities399,769331,013
Other liabilities1,6181,492
Operating lease liabilities, net of current portion38,04241,773
Deferred revenue, net of current portion3,8723,834
Advances from financing companies, net of current portion8,0829,291
Deferred taxes, net50,93975,777
Convertible senior notes, net1,535,2881,225,671
Commitments and contingencies (Note 13)
Stockholders' equity:  
Common stock, $0.001 par value; 300,000,000 shares authorized; 162,840,360 shares and 160,469,325 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively163160
Additional paid-in capital17,358,64517,473,336
Accumulated deficit(15,008,287)(1,421,454)
Accumulated other comprehensive loss(42,776)(6,285)
Total stockholders' equity2,307,74516,045,757
Total liabilities and stockholders' equity$ 4,345,355$ 17,734,608